These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 12825165

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. West Nile virus neutralization by US plasma-derived immunoglobulin products.
    Planitzer CB, Modrof J, Kreil TR.
    J Infect Dis; 2007 Aug 01; 196(3):435-40. PubMed ID: 17597458
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection.
    Ben-Nathan D, Gershoni-Yahalom O, Samina I, Khinich Y, Nur I, Laub O, Gottreich A, Simanov M, Porgador A, Rager-Zisman B, Orr N.
    BMC Infect Dis; 2009 Feb 17; 9():18. PubMed ID: 19222853
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically.
    Morelli MC, Sambri V, Grazi GL, Gaibani P, Pierro A, Cescon M, Ercolani G, Cavrini F, Rossini G, Capobianchi MR, Di Caro A, Menzo S, Pagliaro PP, Ghinelli F, Lazzarotto T, Landini MP, Pinna AD.
    Clin Infect Dis; 2010 Aug 15; 51(4):e34-7. PubMed ID: 20597692
    [Abstract] [Full Text] [Related]

  • 8. Human immunoglobulin as a treatment for West Nile virus infection.
    Agrawal AG, Petersen LR.
    J Infect Dis; 2003 Jul 01; 188(1):1-4. PubMed ID: 12825164
    [No Abstract] [Full Text] [Related]

  • 9. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
    Liu WJ, Wang XJ, Clark DC, Lobigs M, Hall RA, Khromykh AA.
    J Virol; 2006 Mar 01; 80(5):2396-404. PubMed ID: 16474146
    [Abstract] [Full Text] [Related]

  • 10. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
    Iglesias MC, Frenkiel MP, Mollier K, Souque P, Despres P, Charneau P.
    J Gene Med; 2006 Mar 01; 8(3):265-74. PubMed ID: 16308885
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
    Samina I, Havenga M, Koudstaal W, Khinich Y, Koldijk M, Malkinson M, Simanov M, Perl S, Gijsbers L, Weverling GJ, Uytdehaag F, Goudsmit J.
    Vaccine; 2007 Nov 28; 25(49):8338-45. PubMed ID: 17977629
    [Abstract] [Full Text] [Related]

  • 12. The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis.
    Haley M, Retter AS, Fowler D, Gea-Banacloche J, O'Grady NP.
    Clin Infect Dis; 2003 Sep 15; 37(6):e88-90. PubMed ID: 12955669
    [Abstract] [Full Text] [Related]

  • 13. Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques.
    Goverdhan MK, Kulkarni AB, Gupta AK, Tupe CD, Rodrigues JJ.
    Acta Virol; 1992 May 15; 36(3):277-83. PubMed ID: 1360756
    [Abstract] [Full Text] [Related]

  • 14. High clonality of virus-specific T lymphocytes defined by TCR usage in the brains of mice infected with West Nile virus.
    Kitaura K, Fujii Y, Hayasaka D, Matsutani T, Shirai K, Nagata N, Lim CK, Suzuki S, Takasaki T, Suzuki R, Kurane I.
    J Immunol; 2011 Oct 15; 187(8):3919-30. PubMed ID: 21908734
    [Abstract] [Full Text] [Related]

  • 15. Use of RNA interference to prevent lethal murine west nile virus infection.
    Bai F, Wang T, Pal U, Bao F, Gould LH, Fikrig E.
    J Infect Dis; 2005 Apr 01; 191(7):1148-54. PubMed ID: 15747251
    [Abstract] [Full Text] [Related]

  • 16. Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease.
    Kapoor H, Signs K, Somsel P, Downes FP, Clark PA, Massey JP.
    J Clin Virol; 2004 Dec 01; 31(4):289-91. PubMed ID: 15494271
    [Abstract] [Full Text] [Related]

  • 17. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.
    Throsby M, Ter Meulen J, Geuijen C, Goudsmit J, de Kruif J.
    Expert Rev Vaccines; 2007 Apr 01; 6(2):183-91. PubMed ID: 17408368
    [Abstract] [Full Text] [Related]

  • 18. West Nile virus neuroinvasive disease.
    Davis LE, DeBiasi R, Goade DE, Haaland KY, Harrington JA, Harnar JB, Pergam SA, King MK, DeMasters BK, Tyler KL.
    Ann Neurol; 2006 Sep 01; 60(3):286-300. PubMed ID: 16983682
    [Abstract] [Full Text] [Related]

  • 19. Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection.
    Brandler S, Marianneau P, Loth P, Lacôte S, Combredet C, Frenkiel MP, Desprès P, Contamin H, Tangy F.
    J Infect Dis; 2012 Jul 15; 206(2):212-9. PubMed ID: 22551814
    [Abstract] [Full Text] [Related]

  • 20. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT, Gibbs EP, Mellencamp MW, Bowen RA, Seino KK, Zhang S, Beachboard SE, Humphrey PP.
    Equine Vet J; 2007 Nov 15; 39(6):491-7. PubMed ID: 18065305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.